Therapies
Sunday, December 16th, 2012
POSTMEDIA NEWS: DECEMBER 8, 2012 Stroke victims can make astonishing gains in strength in weakened limbs by training the unaffected limbs on the other side of their body, according to new research by the University of Victoria. Neuroscientist Paul Zehr and PhD candidate Katie Dragert designed “ridiculously simple” devices made of wooden boards and cloth […]
News
Sunday, December 16th, 2012

AHA: 12/12/12 Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease and Stroke Statistical […]
News
Sunday, December 16th, 2012

Neurology: December 12, 2012 Objective: Incidence of ischemic stroke (IS) increases with age. Knowledge of factors associated with IS acute outcomes in the oldest-old (≥80 years) is needed to improve quality of care and resource allocation in this age group. Methods: Data are for 769 consecutive IS patients aged ≥60 years (436 aged ≥80 years) admitted to an […]
News
Sunday, December 16th, 2012
Wiley: 12/11/12 Background Evidence is limited on the impact of childhood socioeconomic status, adulthood socioeconomic status and chronic conditions on risk of incident stroke in later life. We aimed to examine these associations using data from a nationally representative sample of the Health and Retirement Study. Methods Stroke-free participants (n = 22 847) aged > 50 years in the Health and […]
News
Sunday, December 16th, 2012
Wiley: 12/11/12 Background Research resources should address the issues that are most important to people affected by a particular healthcare problem. Systematic identification of stroke survivor, caregiver, and health professional priorities would ensure that scarce research resources are directed to areas that matter most to people affected by stroke. Aims We aimed to identify the top […]
News
Sunday, December 16th, 2012
Arch Intern Med. 12/10/2012 Background Between the ages 45 and 65 years, incident stroke is 2 to 3 times more common in blacks than in whites, a difference not explained by traditional stroke risk factors. Methods Stroke risk was assessed in 27 748 black and white participants recruited between 2003 and 2007, who were followed up through […]
Atrial Fibrillation
Friday, December 7th, 2012
Biomedcentral.com: 12/4/12 Atrial fibrillation (AF) is a common arrhythmia of substantial public health importance. Recent evidence demonstrates a heritable component underlying AF, and genetic discoveries have identified common variants associated with the arrhythmia. Ultimately one hopes that the consideration of genetic variation in clinical practice may enhance care and improve health outcomes. In this review we […]
Clinical Trials
Friday, December 7th, 2012
Neurology: 12/5/12 Objective: Beneficial effects of IV tissue plasminogen activator (tPA) in acute ischemic stroke are strongly time-dependent. In the Pre-Hospital Acute Neurological Treatment and Optimization of Medical care in Stroke (PHANTOM-S) study, we undertook stroke treatment using a specialized ambulance, the stroke emergency mobile unit (STEMO), to shorten call-to-treatment time. Methods: The ambulance was staffed with a […]
Clinical Trials
Friday, December 7th, 2012
Wiley: 12/4/12 Objectives Vascular risk factor control may not only prevent stroke but also reduce the risk of dementia. We investigated whether a multifactorial intervention program reduces the incidence of cognitive symptoms one-year after stroke and transient ischemic attack in first ever stroke patients without cognitive decline prior to the stroke. Materials and methods Patients suffering […]
Clinical Trials
Friday, December 7th, 2012
Society of NeuroInterventional Surgery: 12/4/12 The world of intra-arterial therapy for acute ischemic stroke is currently in a state of flux. The IMS-3 trial (randomized trial comparing intravenous therapy with combined intravenous–intra-arterial therapy) was recently stopped prior to completion due to futility. A number of similar trials have either been started (THERAPY and others) or being […]